Cutaneous vasculitis (CV) is a condition characterized clinically mainly by palpable purpura,
involving predominantly the lower extremities, and histologically by leukocytoclastic …

Topic An international, expert-led consensus initiative to develop systematic, evidence-
based recommendations for the treatment of noninfectious uveitis in the era of biologics …

Cardiovascular disease (CV) is the most common cause of premature mortality in patients
with rheumatoid arthritis (RA). This is the result of an accelerated atherosclerotic process …

Background Rheumatoid arthritis is a heterogeneous chronic disease, and no therapeutic
agent has been identified which is universally and persistently effective in all patients. We …

Objective. To assess the possible differences between children (⩽ 20 years) and adults (>
20 years) with Henoch-Schönlein purpura (HSP). Methods. A retrospective study of an …

Objective To assess the efficacy and safety of tocilizumab plus methotrexate (MTX) versus
MTX alone in preventing structural joint damage and improving physical function and …

Background Tofacitinib is an oral Janus kinase inhibitor that is under investigation for the
treatment of psoriatic arthritis. We evaluated tofacitinib in patients with active psoriatic …

Objective To assess the features and therapeutic response of visual manifestations and
cerebrovascular accidents (CVA) in giant cell (temporal) arteritis (GCA) and to identify the …

Objectives The impact of inflammatory rheumatic diseases on COVID-19 severity is poorly
known. Here, we compare the outcomes of a cohort of patients with rheumatic diseases with …

Objective The SELECT‐EARLY trial was undertaken to study the effect of upadacitinib, an
oral, reversible Janus kinase 1–selective inhibitor, as monotherapy in patients with …